Next Biomedical Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	6,789	4,950	3,902	3,014	22,016
Short-Term Investments	9,305	20,766	10,388	11,783	-
Trading Asset Securities	20,904	15,892	-	-	-
Cash & Short-Term Investments	36,998	41,609	14,290	14,797	22,016
Cash Growth	-11.08%	191.17%	-3.43%	-32.79%	226.66%
Accounts Receivable	2,236	1,845	918.64	314.3	118.67
Other Receivables	92.97	321.39	214.28	170.84	86.52
Receivables	2,329	2,167	1,133	485.15	205.19
Inventory	3,036	2,581	2,169	1,940	1,313
Prepaid Expenses	247.28	190.08	155.85	207.32	138.44
Other Current Assets	657.75	341.35	220.7	90.8	65.69
Total Current Assets	43,267	46,888	17,968	17,521	23,739
Property, Plant & Equipment	14,018	11,270	11,428	11,735	11,918
Long-Term Investments	907.78	-	-	2,637	3,737
Other Intangible Assets	310.64	344.38	217.63	222.19	288.71
Long-Term Accounts Receivable	-0	-0	-0	-0	-0
Other Long-Term Assets	761.06	342.75	29.48	21.35	37.51
Total Assets	59,265	58,844	29,643	32,136	39,720
Accounts Payable	47.69	13.37	58.16	45.02	4.1
Accrued Expenses	179.5	126.23	121.14	106.93	96.48
Short-Term Debt	2,160	5,600	5,600	5,600	5,600
Current Portion of Long-Term Debt	4,493	4,539	4,897	4,800	5,200
Current Portion of Leases	39.84	26.37	41.51	35.6	32.24
Other Current Liabilities	1,124	1,579	714.37	452.97	2,115
Total Current Liabilities	8,044	11,884	11,433	11,041	13,048
Long-Term Debt	950.66	763.5	933.54	500	20,873
Long-Term Leases	68.49	20.58	46.9	81.63	46.55
Pension & Post-Retirement Benefits	944.49	749.44	559.45	471.1	385.02
Other Long-Term Liabilities	1,151	235.35	218.84	368.8	284.7
Total Liabilities	11,158	13,653	13,191	12,462	34,636
Common Stock	4,102	4,043	3,174	3,110	3,105
Additional Paid-In Capital	111,130	107,234	61,632	60,679	60,603
Retained Earnings	-70,597	-70,181	-72,984	-65,367	-59,673
Comprehensive Income & Other	3,472	4,095	2,277	1,324	1,049
Total Common Equity	48,107	45,191	-5,901	-253.84	5,084
Shareholders' Equity	48,107	45,191	16,452	19,674	5,084
Total Liabilities & Equity	59,265	58,844	29,643	32,136	39,720
Total Debt	7,712	10,949	11,519	11,017	31,751
Net Cash (Debt)	29,286	30,659	2,771	3,780	-9,735
Net Cash Growth	-4.48%	1006.61%	-26.70%	-	-
Net Cash Per Share	3577.36	4256.48	441.28	608.67	-2011.96
Filing Date Shares Outstanding	8.42	8.09	6.28	6.21	4.84
Total Common Shares Outstanding	8.42	8.09	6.28	6.21	4.84
Working Capital	35,224	35,004	6,536	6,480	10,691
Book Value Per Share	5716.70	5588.37	-939.89	-40.88	1050.64
Tangible Book Value	47,796	44,847	-6,119	-476.03	4,795
Tangible Book Value Per Share	5679.79	5545.78	-974.55	-76.65	990.97
Land	5,618	5,277	5,277	5,277	5,277
Buildings	7,316	5,786	5,786	5,786	5,786
Machinery	2,566	1,598	1,430	1,397	1,504
Construction In Progress	215.37	99.29	119.06	150.11	188.87

Source: S&P Global Market Intelligence. Standard template. Financial Sources.